NIAID supports the study of global research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases and conditions. In addition to advancing these scientific goals, NIAID global research helps to improve the health of millions of people around the world, to protect the United States against infectious disease threats, and to promote international economic and political stability. Together, these efforts establish NIAID as a leader in global health.
Liberia-U.S. Clinical Research Partnership Opens Trial to Test Ebola Treatments—Feb. 27, 2015
NIH Expands Key Tuberculosis Research Program—Feb. 18, 2015
NIH-Sponsored HIV Vaccine Trial Launches in South Africa—Feb. 18, 2015
NIH-Supported Clinical Trials to Evaluate Long-Acting, Injectable Antiretroviral Drugs to Prevent HIV Infection—Feb. 18, 2015
All Global Research News Releases
News From NIAID-Supported Institutions
Last Updated February 27, 2015